270 related articles for article (PubMed ID: 26992378)
21. Antiangiogenic therapy in brain tumors.
Lakka SS; Rao JS
Expert Rev Neurother; 2008 Oct; 8(10):1457-73. PubMed ID: 18928341
[TBL] [Abstract][Full Text] [Related]
22. Glioma progression through the prism of heat shock protein mediated extracellular matrix remodeling and epithelial to mesenchymal transition.
Rajesh Y; Biswas A; Mandal M
Exp Cell Res; 2017 Oct; 359(2):299-311. PubMed ID: 28844885
[TBL] [Abstract][Full Text] [Related]
23. The role of contortrostatin, a snake venom disintegrin, in the inhibition of tumor progression and prolongation of survival in a rodent glioma model.
Pyrko P; Wang W; Markland FS; Swenson SD; Schmitmeier S; Schönthal AH; Chen TC
J Neurosurg; 2005 Sep; 103(3):526-37. PubMed ID: 16235686
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of glioma angiogenesis and invasion by SI-27, an anti-matrix metalloproteinase agent in a rat brain tumor model.
Yoshida D; Takahashi H; Teramoto A
Neurosurgery; 2004 May; 54(5):1213-20; discussion 1220-1. PubMed ID: 15113477
[TBL] [Abstract][Full Text] [Related]
25. Proteases and glioma angiogenesis.
Lakka SS; Gondi CS; Rao JS
Brain Pathol; 2005 Oct; 15(4):327-41. PubMed ID: 16389945
[TBL] [Abstract][Full Text] [Related]
26. Anti-invasive and antiangiogenic effects of MMI-166 on malignant glioma cells.
Nakabayashi H; Yawata T; Shimizu K
BMC Cancer; 2010 Jun; 10():339. PubMed ID: 20587068
[TBL] [Abstract][Full Text] [Related]
27. Biological mechanisms of glioma invasion and potential therapeutic targets.
Tysnes BB; Mahesparan R
J Neurooncol; 2001 Jun; 53(2):129-47. PubMed ID: 11716066
[TBL] [Abstract][Full Text] [Related]
28. Re: angiogenesis and antiangiogenic therapy for malignant gliomas.
Kepes JJ
Brain Tumor Pathol; 2005; 22(1):51. PubMed ID: 18095105
[No Abstract] [Full Text] [Related]
29. AMPA receptors promote perivascular glioma invasion via beta1 integrin-dependent adhesion to the extracellular matrix.
Piao Y; Lu L; de Groot J
Neuro Oncol; 2009 Jun; 11(3):260-73. PubMed ID: 18957620
[TBL] [Abstract][Full Text] [Related]
30. Targeting the tumor vasculature to improve the efficacy of oncolytic virus therapy.
Rhim JH; Tosato G
J Natl Cancer Inst; 2007 Dec; 99(23):1739-41. PubMed ID: 18042930
[No Abstract] [Full Text] [Related]
31. [Role of extracellular matrix degradation enzyme for glioma invasion].
Nakada M
Nihon Rinsho; 2005 Sep; 63 Suppl 9():55-60. PubMed ID: 16201500
[No Abstract] [Full Text] [Related]
32. Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2.
Bello L; Lucini V; Carrabba G; Giussani C; Machluf M; Pluderi M; Nikas D; Zhang J; Tomei G; Villani RM; Carroll RS; Bikfalvi A; Black PM
Cancer Res; 2001 Dec; 61(24):8730-6. PubMed ID: 11751392
[TBL] [Abstract][Full Text] [Related]
33. Invasion as limitation to anti-angiogenic glioma therapy.
Lamszus K; Kunkel P; Westphal M
Acta Neurochir Suppl; 2003; 88():169-77. PubMed ID: 14531575
[TBL] [Abstract][Full Text] [Related]
34. Molecular events implicated in brain tumor angiogenesis and invasion.
Zagzag D; Friedlander DR; Margolis B; Grumet M; Semenza GL; Zhong H; Simons JW; Holash J; Wiegand SJ; Yancopoulos GD
Pediatr Neurosurg; 2000 Jul; 33(1):49-55. PubMed ID: 11025423
[TBL] [Abstract][Full Text] [Related]
35. Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion.
Grobben B; De Deyn PP; Slegers H
Cell Tissue Res; 2002 Dec; 310(3):257-70. PubMed ID: 12457224
[TBL] [Abstract][Full Text] [Related]
36. Cell-extracellular matrix interaction in glioma invasion.
Goldbrunner RH; Bernstein JJ; Tonn JC
Acta Neurochir (Wien); 1999; 141(3):295-305; discussion 304-5. PubMed ID: 10214487
[TBL] [Abstract][Full Text] [Related]
37. Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma.
Kessler T; Sahm F; Blaes J; Osswald M; Rübmann P; Milford D; Urban S; Jestaedt L; Heiland S; Bendszus M; Hertenstein A; Pfenning PN; Ruiz de Almodóvar C; Wick A; Winkler F; von Deimling A; Platten M; Wick W; Weiler M
Oncotarget; 2015 Oct; 6(31):31050-68. PubMed ID: 25682871
[TBL] [Abstract][Full Text] [Related]
38. Targeting angiogenesis with compounds from the extracellular matrix.
Belotti D; Foglieni C; Resovi A; Giavazzi R; Taraboletti G
Int J Biochem Cell Biol; 2011 Dec; 43(12):1674-85. PubMed ID: 21864705
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of glioma formation: iterative perivascular glioma growth and invasion leads to tumor progression, VEGF-independent vascularization, and resistance to antiangiogenic therapy.
Baker GJ; Yadav VN; Motsch S; Koschmann C; Calinescu AA; Mineharu Y; Camelo-Piragua SI; Orringer D; Bannykh S; Nichols WS; deCarvalho AC; Mikkelsen T; Castro MG; Lowenstein PR
Neoplasia; 2014 Jul; 16(7):543-61. PubMed ID: 25117977
[TBL] [Abstract][Full Text] [Related]
40. [Anti-angiogenesis treatment for brain tumors--present and future].
Takano S
Nihon Rinsho; 2005 Sep; 63 Suppl 9():534-9. PubMed ID: 16201577
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
